Second Course of Adjuvant Treatment Feasible in Stage III to IV Melanoma

Recurrence-free survival for second course of adjuvant treatment is lower with PD-1 checkpoint inhibitors versus BRAF + MEK inhibitors
melanoma skin cancer
Adobe Stock
Medically Reviewed By:
Meeta Shah, M.D.
Published on: 
Updated on: 
Loading content, please wait...

Related Stories

No stories found.
logo
www.healthday.com